EX-99.1 2 c04458exv99w1.htm EXHIBIT 99.1 Exhibit 99.1
Exhibit 99.1
(IMAGE)
FOR IMMEDIATE RELEASE
  4714 Gettysburg Road
Mechanicsburg, PA
17055

NYSE Symbol: SEM
Select Medical Holdings Corporation Announces Results for
Second Quarter Ended June 30, 2010
MECHANICSBURG, PENNSYLVANIA — August 5, 2010 — Select Medical Holdings Corporation (“Select”) (NYSE: SEM), today announced results for its second quarter ended June 30, 2010.
For the second quarter ended June 30, 2010, net operating revenues increased 3.6% to $579.9 million compared to $559.5 million for the same quarter, prior year. Income from operations increased 11.0% to $72.6 million compared to $65.4 million for the same quarter, prior year. Net income attributable to Select increased 23.6% to $24.5 million compared to $19.8 million for the same quarter, prior year. Net income attributable to Select for the quarter ended June 30, 2009 included a gain on early retirement of debt, net of tax, of $2.0 million. Additionally, net income before interest, income taxes, depreciation and amortization, gain on early retirement of debt, stock compensation expense and other income (“Adjusted EBITDA”) for the second quarter increased 7.2% to $89.6 million compared to $83.6 million for the same quarter, prior year. A reconciliation of net income to Adjusted EBITDA is attached to this release. Income per common share for the second quarter ended June 30, 2010 was $0.15 on a fully diluted basis and weighted average diluted shares outstanding were 159,975,000. On September 30, 2009, Select completed an initial public offering that resulted in the issuance of 30,000,000 shares of common stock. On October 28, 2009, the underwriters exercised their over-allotment option to purchase an additional 3,603,000 shares of common stock. Upon completion of the initial public offering, Select’s participating preferred stock converted into a total of 64,277,000 common shares.
Select’s income per common share for the quarter ended June 30, 2009 was $0.19, which included a non-recurring gain related to the early retirement of debt. Excluding this item, on an adjusted basis income available to common stockholders was $0.16 per diluted share for the quarter ended June 30, 2009. A reconciliation of net income per share to adjusted net income per share is attached to this release.
For the six months ended June 30, 2010, net operating revenues increased 3.9% to $1,164.7 million compared to $1,120.7 million for the same period, prior year. Income from operations increased 9.2% to $145.2 million compared to $133.0 million for the same period, prior year. Net income attributable to Select increased 8.7% to $48.7 million compared to $44.8 million for the same period, prior year. Net income attributable to Select for the six months ended June 30, 2009 includes a gain on early retirement of debt, net of tax, of $8.9 million. Additionally, Adjusted EBITDA for the six months ended June 30, 2010 increased 6.6% to $180.5 million compared to $169.3 million for the same period, prior year. A reconciliation of net income to Adjusted EBITDA is attached to this release. Income per common share for the six months ended June 30, 2010 was $0.30 on a fully diluted basis and weighted average diluted shares outstanding were 159,984,000. On September 30, 2009, Select completed an initial public offering that resulted in the issuance of 30,000,000 shares of common stock. On October 28, 2009, the underwriters exercised their over-allotment option to purchase an additional 3,603,000 shares of common stock. Upon completion of the initial public offering, Select’s participating preferred stock converted into a total of 64,277,000 common shares.

 

 


 

Select’s income per common share for the six months ended June 30, 2009 was $0.47, which included a non-recurring gain related to the early retirement of debt. Excluding this item, on an adjusted basis income available to common stockholders was $0.34 per diluted share for the six months ended June 30, 2009. A reconciliation of net income per share to adjusted net income per share is attached to this release.
Specialty Hospitals
At June 30, 2010, Select operated 89 long term acute care hospitals and six acute medical rehabilitation hospitals. This compares to 87 long term acute care hospitals and five acute medical rehabilitation hospitals operated at June 30, 2009. For the second quarter of 2010, net operating revenues for all of Select’s hospitals increased 4.3% to $403.1 million compared to $386.3 million for the same quarter, prior year. Total patient days for the second quarter of 2010 were 264,898, admissions were 10,616 and net revenue per patient day was $1,474. This compares to 252,710 days, 10,504 admissions and net revenue per patient day of $1,491 for the same quarter, prior year. For the hospitals opened or acquired as of January 1, 2009 and operated by Select throughout both periods, patient days in the second quarter of 2010 were 258,884 and admissions were 10,304, compared to 251,136 days and 10,433 admissions in the same quarter, prior year. Adjusted EBITDA for the specialty hospital segment increased 3.4% to $73.3 million compared to $71.0 million for the same quarter, prior year. The Adjusted EBITDA margin for the segment was 18.2% for the second quarter of 2010, compared to 18.4% for the same quarter, prior year. The Adjusted EBITDA margin for the hospitals opened or acquired as of January 1, 2009 and operated by Select throughout both periods was 18.5% for the second quarter of 2010, compared to 18.4% for the same quarter, prior year.
For the six months ended June 30, 2010, net operating revenues for all of Select’s hospitals increased 4.5% to $814.8 million compared to $779.6 million for the same period, prior year. Total patient days for the six months ended June 30, 2010 were 532,746, admissions were 21,717 and net revenue per patient day was $1,483. This compares to 508,983 days, 21,309 admissions and net revenue per patient day of $1,494 for the same period, prior year. For the hospitals opened or acquired as of January 1, 2009 and operated by Select throughout both periods, patient days for the six months ended June 30, 2010 were 521,823, and admissions were 21,122, compared to 505,403 days and 21,164 admissions in the same period, prior year. Adjusted EBITDA for the segment for the six months ended June 30, 2010 increased 5.8% to $156.2 million compared to $147.7 million for the same period, prior year. The Adjusted EBITDA margin for the segment for the six months ended June 30, 2010 was 19.2%, compared to 19.0% for the same period, prior year. The Adjusted EBITDA margin for the hospitals opened or acquired as of January 1, 2009 and operated by Select throughout both periods was 19.7% for the six months ended June 30, 2010, compared to 19.0% for the same period, prior year.
Outpatient Rehabilitation
At June 30, 2010, Select operated 953 outpatient clinics. This compares to 948 outpatient clinics at June 30, 2009. For the second quarter of 2010, net operating revenues for the outpatient rehabilitation segment increased 2.1% to $176.8 million compared to $173.2 million for the same quarter, prior year. Adjusted EBITDA for the segment for the second quarter increased 2.6% to $26.0 million compared to $25.3 million for the same quarter, prior year. The Adjusted EBITDA margin for the segment for the quarter was 14.7% compared to 14.6% in the same quarter, prior year. Patient visits for the quarter were 1,172,212 compared to 1,163,341 for the same quarter, prior year. Net revenue per visit was $101 in both quarters.
For the six months ended June 30, 2010, net operating revenues were $349.9 million compared to $341.0 million for the same period, prior year. Adjusted EBITDA for the six months ended June 30, 2010 decreased 0.2% to $46.5 million compared to $46.6 million for the same period, prior year. The Adjusted EBITDA margin for the six months ended June 30, 2010 was 13.3% compared to 13.7% in the same period, prior year. Patient visits for the six months ended June 30, 2010 were 2,298,170 compared to 2,259,637 for the same period, prior year. Net revenue per visit was $101 for the six months ended June 30, 2010 compared to $102 for the same period, prior year.

 

 


 

Agreement to Purchase Regency Hospital Company, L.L.C.
On June 18, 2010, the Company entered into an agreement to acquire all the issued and outstanding equity securities of Regency Hospital Company, L.L.C. (“Regency”) an operator of long-term acute care hospitals, for approximately $210 million, including certain assumed liabilities. The purchase price is subject to adjustment based on Regency’s net working capital on the closing date.
Regency operates a network of 23 long-term acute care hospitals, located in 9 states. The transaction, which is expected to close in the third quarter of 2010, is subject to a number of closing conditions, including clearance under the Hart-Scott-Rodino antitrust Improvements Act of 1976, as amended, and receipt of certain healthcare regulatory approvals.
Business Outlook
The Company intends to revise its 2010 business outlook upon the closing of the Regency Transaction.
Conference Call
The Company will host a conference call regarding its second quarter results and its business outlook on Friday, August 6, 2010, at 9:00 am EDT. The domestic dial in number for the call is 1-866-788-0541. The international dial in number is 1-857-350-1679. The passcode for the call is 10011638. The conference call will be webcast simultaneously and can be accessed at Select Medical Holdings Corporation’s website http://www.selectmedicalholdings.com.
For those unable to participate in the conference call, a replay will be available until 11:59 pm EDT, Friday, August 13, 2010. The replay number is 1-888-286-8010 (domestic) or 1-617-801-6888 (international). The passcode for the replay will be 70263211. The replay can also be accessed at Select Medical Holdings Corporation’s website, http://www.selectmedicalholdings.com.
* * * * *
Select Medical Holdings Corporation is a leading operator of specialty hospitals in the United States. As of June 30, 2010, Select operated 89 long term acute care hospitals and 6 acute medical rehabilitation hospitals in 25 states. Select is also a leading operator of outpatient rehabilitation clinics in the United States, with approximately 953 locations in 36 states and the District of Columbia. Select also provides medical rehabilitation services on a contract basis at nursing homes, hospitals, assisted living and senior care centers, schools and worksites. Information about Select is available at http://www.selectmedicalholdings.com/

 

 


 

Certain statements contained herein that are not descriptions of historical facts are “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements due to factors including the following:
   
additional changes in government reimbursement for our services, including changes that will result from the expiration of the moratorium for long term acute care hospitals established by the SCHIP Extension Act of 2007, the American Recovery and Reinvestment Act, and the Patient Protection and Affordable Care Act may result in a reduction in net operating revenues, an increase in costs and a reduction in profitability;
 
   
the failure of our specialty hospitals to maintain their Medicare certifications as such may cause our net operating revenues and profitability to decline;
 
   
the failure of our facilities operated as “hospitals within hospitals” or HIHs, to qualify as hospitals separate from their host hospitals may cause our net operating revenues and profitability to decline;
 
   
a government investigation or assertion that we have violated applicable regulations may result in sanctions or reputational harm and increased costs;
 
   
future acquisitions or joint ventures may prove difficult or unsuccessful, use significant resources or expose us to unforeseen liabilities;
 
   
private third-party payors for our services may undertake future cost containment initiatives that limit our future net operating revenues and profitability;
 
   
the failure to maintain established relationships with the physicians in the areas we serve could reduce our net operating revenues and profitability;
 
   
shortages in qualified nurses or therapists could increase our operating costs significantly;
 
   
competition may limit our ability to grow and result in a decrease in our net operating revenues and profitability;
 
   
the loss of key members of our management team could significantly disrupt our operations;
 
   
the effect of claims asserted against us or lack of adequate available insurance could subject us to substantial uninsured liabilities;
 
   
other factors discussed from time to time in our filings with the Securities and Exchange Commission, including factors under the heading “Risk Factors” in our annual report on Form 10-K.
Investor inquiries:
Joel T. Veit
Vice President and Treasurer
717-972-1100
ir@selectmedicalcorp.com
SOURCE: Select Medical Holdings Corporation

 

 


 

I. Condensed Consolidated Statements of Operations
(In thousands, except per share amounts)
(unaudited)
For the Three Months Ended June 30, 2009 and 2010
                         
                    %  
    2009     2010     Change  
Net operating revenues
  $ 559,535     $ 579,877       3.6 %
 
                       
Costs and expenses:
                       
Cost of services
    453,011       470,044       3.8 %
General and administrative
    12,885       9,802       (23.9 )%
Bad debt expense
    10,312       10,845       5.2 %
Depreciation and amortization
    17,939       16,610       (7.4 )%
 
                 
 
                       
Income from operations
    65,388       72,576       11.0 %
 
                       
Gain on early retirement of debt
    3,562             N/M  
Other income
          182       N/M  
Interest income
    28             N/M  
Interest expense
    (33,658 )     (29,279 )     (13.0 )%
 
                 
 
                       
Income from operations before income taxes
    35,320       43,479       23.1 %
 
                       
Income tax expense
    15,137       17,306       14.3 %
 
                 
 
                       
Net income
    20,183       26,173       29.7 %
 
                       
Less: Net income attributable to non-controlling interests
    391       1,711       337.6 %
 
                 
 
                       
Net income attributable to Select Medical Holdings Corporation
    19,792       24,462       23.6 %
 
                       
Less: Preferred dividends
    6,508             N/M  
 
                 
 
                       
Net income available to common stockholders and participating securities
  $ 13,284     $ 24,462       84.1 %
 
                 
 
                       
Income per common share:
                       
Basic
  $ 0.20     $ 0.15          
Diluted
  $ 0.19     $ 0.15          
 
                       
Weighted average shares outstanding (1):
                       
Basic
    60,632       159,709          
Diluted
    61,114       159,975          
     
N/M = Not Meaningful
 
(1)  
On September 30, 2009, Select completed an initial public offering that resulted in the issuance of 30,000 shares of common stock. On October 28, 2009, the underwriters exercised their over-allotment option to purchase an additional 3,603 shares of common stock. Upon completion of the initial public offering, Select’s participating preferred stock converted into a total of 64,277 common shares.

 

 


 

II. Condensed Consolidated Statements of Operations
(In thousands, except per share amounts)
(unaudited)
For the Six Months Ended June 30, 2009 and 2010
                         
                    %  
    2009     2010     Change  
Net operating revenues
  $ 1,120,707     $ 1,164,690       3.9 %
 
                       
Costs and expenses:
                       
Cost of services
    904,405       942,421       4.2 %
General and administrative
    25,660       22,591       (12.0 )%
Bad debt expense
    21,958       20,132       (8.3 )%
Depreciation and amortization
    35,670       34,321       (3.8 )%
 
                 
 
                       
Income from operations
    133,014       145,225       9.2 %
 
                       
Gain on early retirement of debt
    15,316             N/M  
Other income
          316       N/M  
Interest income
    80             N/M  
Interest expense
    (68,330 )     (59,321 )     (13.2 )%
 
                 
 
                       
Income from operations before income taxes
    80,080       86,220       7.7 %
 
                       
Income tax expense
    33,880       34,415       1.6 %
 
                 
 
                       
Net income
    46,200       51,805       12.1 %
 
                       
Less: Net income attributable to non-controlling interests
    1,412       3,117       120.8 %
 
                 
 
                       
Net income attributable to Select Medical Holdings Corporation
    44,788       48,688       8.7 %
 
                       
Less: Preferred dividends
    12,870             N/M  
 
                 
 
                       
Net income available to common stockholders and participating securities
  $ 31,918     $ 48,688       52.5 %
 
                 
 
                       
Income per common share:
                       
Basic
  $ 0.47     $ 0.30          
Diluted
  $ 0.47     $ 0.30          
 
                       
Weighted average shares outstanding (1):
                       
Basic
    60,509       159,686          
Diluted
    60,991       159,984          
     
N/M = Not Meaningful
 
(1)  
On September 30, 2009, Select completed an initial public offering that resulted in the issuance of 30,000 shares of common stock. On October 28, 2009, the underwriters exercised their over-allotment option to purchase an additional 3,603 shares common stock. Upon completion of the initial public offering, Select’s participating preferred stock converted into a total of 64,277 common shares.

 

 


 

III. Condensed Consolidated Balance Sheets
(In thousands)
(unaudited)
                 
    December 31,     June 30,  
    2009     2010  
ASSETS
               
Cash
  $ 83,680     $ 128,753  
Accounts receivable, net
    307,079       338,320  
Current deferred tax asset
    48,535       40,808  
Prepaid income taxes
    11,179       6,841  
Other current assets
    24,240       24,730  
 
           
Total Current Assets
    474,713       539,452  
Property and equipment, net
    466,131       459,567  
Goodwill
    1,548,269       1,548,269  
Other identifiable intangibles
    65,297       63,468  
Assets held for sale
    11,342       11,342  
Other assets
    36,481       38,025  
 
           
Total Assets
  $ 2,602,233     $ 2,660,123  
 
           
LIABILITIES AND EQUITY
               
Payables and accruals
  $ 299,796     $ 296,972  
Current portion of long-term debt
    4,145       102,410  
 
           
Total Current Liabilities
    303,941       399,382  
Long-term debt, net of current portion
    1,401,426       1,305,069  
Non-current deferred tax liability
    66,768       66,604  
Other non-current liabilities
    60,543       61,712  
Total equity
    769,555       827,356  
 
           
Total Liabilities and Equity
  $ 2,602,233     $ 2,660,123  
 
           

 

 


 

IV. Condensed Consolidated Statements of Cash Flows
(In thousands)
(unaudited)
For the Six Months Ended June 30, 2009 and 2010
                 
    2009     2010  
Operating activities
               
Net income
  $ 46,200     $ 51,805  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    35,670       34,321  
Provision for bad debts
    21,958       20,132  
Gain on early retirement of debt
    (15,316 )      
Loss from disposal of assets
    117       660  
Non-cash gain from interest rate swaps
          (316 )
Non-cash stock compensation expense
    594       945  
Amortization of debt discount
    815       918  
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
               
Accounts receivable
    (49,155 )     (51,373 )
Other current assets
    (667 )     (495 )
Other assets
    4,242       (1,140 )
Accounts payable
    (3,693 )     (8,796 )
Due to third-party payors
    (216 )     587  
Accrued expenses and deferred income taxes
    16,686       11,471  
 
           
Net cash provided by operating activities
    57,235       58,719  
 
           
 
               
Investing activities
               
Purchases of property and equipment
    (20,981 )     (26,454 )
Proceeds from sale of property
    1,341        
 
           
Net cash used in investing activities
    (19,640 )     (26,454 )
 
           
 
               
Financing activities
               
Borrowings on revolving credit facility
    138,000        
Payments on revolving credit facility
    (173,000 )      
Payment on credit facility term loan
    (3,400 )      
Repurchase of 7 5/8% senior subordinated notes
    (30,114 )      
Borrowings of other debt
    5,184       5,015  
Principal payments on seller and other debt
    (3,891 )     (4,442 )
Repurchase of common and preferred stock
    (80 )      
Proceeds from issuance of common stock
    24       125  
Payment of initial public offering costs
    (417 )      
Proceeds from (repayment of) bank overdrafts
    (4,658 )     14,201  
Distributions to non-controlling interests
    (1,814 )     (2,091 )
 
           
Net cash provided by (used in) financing activities
    (74,166 )     12,808  
 
           
 
               
Net increase (decrease) in cash and cash equivalents
    (36,571 )     45,073  
 
               
Cash and cash equivalents at beginning of period
    64,260       83,680  
 
           
Cash and cash equivalents at end of period
  $ 27,689     $ 128,753  
 
           
 
               
Supplemental Cash Flow Information
               
Cash paid for interest
  $ 64,710     $ 55,928  
Cash paid for taxes
  $ 11,090     $ 24,664  

 

 


 

V. Key Statistics
(unaudited)
For the Three Months Ended June 30, 2009 and 2010
                         
                    %  
    2009     2010     Change  
 
                       
Specialty Hospitals (a)
                       
 
                       
Number of hospitals — end of period
    92       95       3.3 %
 
                       
Net operating revenues (,000)
  $ 386,331     $ 403,079       4.3 %
 
                       
Number of patient days
    252,710       264,898       4.8 %
 
                       
Number of admissions
    10,504       10,616       1.1 %
 
                       
Net revenue per patient day (b)
  $ 1,491     $ 1,474       (1.1 )%
 
                       
Adjusted EBITDA (,000)
  $ 70,960     $ 73,344       3.4 %
 
                       
Adjusted EBITDA margin — all hospitals
    18.4 %     18.2 %     (1.1 )%
Adjusted EBITDA margin — same store hospitals (c)
    18.4 %     18.5 %     0.5 %
 
                       
Outpatient Rehabilitation
                       
 
                       
Number of clinics — end of period
    948       953       0.5 %
 
                       
Net operating revenues (,000)
  $ 173,190     $ 176,785       2.1 %
 
                       
Number of visits
    1,163,341       1,172,212       0.8 %
 
                       
Revenue per visit (d)
  $ 101     $ 101       0.0 %
 
                       
Adjusted EBITDA (,000)
  $ 25,294     $ 25,956       2.6 %
 
                       
Adjusted EBITDA margin
    14.6 %     14.7 %     0.7 %
     
(a)  
Specialty hospitals consist of long term acute care hospitals and acute medical rehabilitation hospitals.
 
(b)  
Net revenue per patient day is calculated by dividing specialty hospital direct patient service revenue by the total number of patient days.
 
(c)  
Adjusted EBITDA margin — same store hospitals represents the Adjusted EBITDA margin for those hospitals opened or acquired before January 1, 2009 and operated throughout both periods.
 
(d)  
Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by the total number of visits. For purposes of this computation, outpatient rehabilitation clinic revenue does not include managed clinics or contract services revenue.

 

 


 

VI. Key Statistics
(unaudited)
For the Six Months Ended June 30, 2009 and 2010
                         
                    %  
    2009     2010     Change  
 
                       
Specialty Hospitals (a)
                       
 
                       
Number of hospitals — end of period
    92       95       3.3 %
 
                       
Net operating revenues (,000)
  $ 779,563     $ 814,764       4.5 %
 
                       
Number of patient days
    508,983       532,746       4.7 %
 
                       
Number of admissions
    21,309       21,717       1.9 %
 
                       
Net revenue per patient day (b)
  $ 1,494     $ 1,483       (0.7 )%
 
                       
Adjusted EBITDA (,000)
  $ 147,741     $ 156,241       5.8 %
 
                       
Adjusted EBITDA margin — all hospitals
    19.0 %     19.2 %     1.1 %
Adjusted EBITDA margin — same store hospitals (c)
    19.0 %     19.7 %     3.7 %
 
                       
Outpatient Rehabilitation
                       
 
                       
Number of clinics — end of period
    948       953       0.5 %
 
                       
Net operating revenues (,000)
  $ 341,009     $ 349,850       2.6 %
 
                       
Number of visits
    2,259,637       2,298,170       1.7 %
 
                       
Revenue per visit (d)
  $ 102     $ 101       (1.0 )%
 
                       
Adjusted EBITDA (,000)
  $ 46,578     $ 46,474       (0.2 )%
 
                       
Adjusted EBITDA margin
    13.7 %     13.3 %     (2.9 )%
     
(a)  
Specialty hospitals consist of long term acute care hospitals and acute medical rehabilitation hospitals.
 
(b)  
Net revenue per patient day is calculated by dividing specialty hospital direct patient service revenue by the total number of patient days.
 
(c)  
Adjusted EBITDA margin — same store hospitals represents the Adjusted EBITDA margin for those hospitals opened or acquired before January 1, 2009 and operated throughout both periods.
 
(d)  
Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by the total number of visits. For purposes of this computation, outpatient rehabilitation clinic revenue does not include managed clinics or contract services revenue.

 

 


 

VII. Net Income to Adjusted EBITDA Reconciliation
(In thousands)
(unaudited)
For the Three and Six Months Ended June 30, 2009 and 2010
The following table reconciles net income to Adjusted EBITDA for Select. Adjusted EBITDA is used by Select to report its segment performance. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation and amortization, stock compensation expense, other income and gain on early retirement of debt. We believe that the presentation of Adjusted EBITDA is important to investors because Adjusted EBITDA is used by management to evaluate financial performance and determine resource allocation for each of our operating units.
Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles. Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies.
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2009     2010     2009     2010  
Net income
  $ 20,183     $ 26,173     $ 46,200     $ 51,805  
Income tax expense
    15,137       17,306       33,880       34,415  
Other income
          (182 )           (316 )
Interest expense, net
    33,630       29,279       68,250       59,321  
Gain on early retirement of debt
    (3,562 )           (15,316 )      
Stock compensation expense
                               
Included in general and administrative
    241       111       483       291  
Included in cost of services
    58       326       111       654  
Depreciation and amortization
    17,939       16,610       35,670       34,321  
 
                       
Adjusted EBITDA
  $ 83,626     $ 89,623     $ 169,278     $ 180,491  
 
                       
 
                               
Specialty hospitals
  $ 70,960     $ 73,344     $ 147,741     $ 156,241  
Outpatient rehabilitation
    25,294       25,956       46,578       46,474  
Other (1)
    (12,628 )     (9,677 )     (25,041 )     (22,224 )
 
                       
Adjusted EBITDA
  $ 83,626     $ 89,623     $ 169,278     $ 180,491  
 
                       
     
(1)  
Other primarily includes general and administrative costs.

 

 


 

The following tables reconcile specialty hospital same store information.
                 
    Three Months Ended  
    June 30, 2009     June 30, 2010  
Specialty hospitals net operating revenue
  $ 386,331     $ 403,079  
Less: Specialty hospitals in development, opened, acquired or closed after 1/1/09
    2,550       10,748  
 
           
Specialty hospitals same store net operating revenue
  $ 383,781     $ 392,331  
 
           
 
               
Specialty hospitals Adjusted EBITDA
  $ 70,960     $ 73,344  
Less: Specialty hospitals in development, opened, acquired or closed after 1/1/09
    338       582  
 
           
Specialty hospitals same store Adjusted EBITDA
  $ 70,622     $ 72,762  
 
           
 
               
All specialty hospitals Adjusted EBITDA margin
    18.4 %     18.2 %
Specialty hospitals same store Adjusted EBITDA margin
    18.4 %     18.5 %
                 
    Six Months Ended  
    June 30, 2009     June 30, 2010  
Specialty hospitals net operating revenue
  $ 779,563     $ 814,764  
Less: Specialty hospitals in development, opened, acquired or closed after 1/1/09
    5,572       19,575  
 
           
Specialty hospitals same store net operating revenue
  $ 773,991     $ 795,189  
 
           
 
               
Specialty hospitals Adjusted EBITDA
  $ 147,741     $ 156,241  
Less: Specialty hospitals in development, opened, acquired or closed after 1/1/09
    392       (490 )
 
           
Specialty hospitals same store Adjusted EBITDA
  $ 147,349     $ 156,731  
 
           
 
               
All specialty hospitals Adjusted EBITDA margin
    19.0 %     19.2 %
Specialty hospitals same store Adjusted EBITDA margin
    19.0 %     19.7 %

 

 


 

VIII. Reconciliation of Net Income Per Share to Adjusted Net Income Per Share
(In thousands, except per share amounts)
(unaudited)
For the Three Months Ended June 30, 2009 and 2010
                                 
    2009     Per Share (a)     2010     Per Share (a)  
Net income
  $ 20,183     $ 0.33     $ 26,173     $ 0.16  
Net income attributable to non-controlling interests
    391       0.01       1,711       0.01  
 
                       
Net income attributable to Select Medical Holdings Corporation
    19,792       0.32       24,462       0.15  
Less: Preferred dividends
    6,508       0.10             0.00  
 
                       
 
                               
Net income available to common stockholders and participating securities
    13,284       0.22       24,462       0.15  
 
                               
Gain on early retirement of debt
    (3,562 )     (0.06 )            
Estimated income tax expense (b)
    1,502       0.02              
 
                       
 
    11,224       0.18       24,462       0.15  
 
                               
Allocation to participating securities:
                               
Less: Earnings allocated to preferred stockholders
    1,095       0.02             0.00  
Less: Earnings allocated to unvested restricted stockholders
    136       0.00       46       0.00  
 
                       
 
                               
Adjusted net income available to common stockholders
  $ 9,993     $ 0.16     $ 24,416     $ 0.15  
 
                           
Adjustment for dilution
            0.00               0.00  
 
                           
 
                               
Adjusted net income available to common stockholders — diluted shares
          $ 0.16             $ 0.15  
 
                           
 
                               
Weighted average common shares outstanding:
                               
Basic
            60,632               159,709  
Diluted
            61,114               159,975  
     
(a)  
Per share amounts for each period presented are based on basic weighted average common shares outstanding for all amounts except adjusted net income available to common stockholders — diluted shares, which is based on diluted shares outstanding.
 
(b)  
Represents the tax expense on the adjustments to net income.

 

 


 

IX. Reconciliation of Net Income Per Share to Adjusted Net Income Per Share
(In thousands, except per share amounts)
(unaudited)
For the Six Months Ended June 30, 2009 and 2010
                                 
    2009     Per Share (a)     2010     Per Share (a)  
Net income
  $ 46,200     $ 0.76     $ 51,805     $ 0.32  
Net income attributable to non-controlling interests
    1,412       0.02       3,117       0.02  
 
                       
Net income attributable to Select Medical Holdings Corporation
    44,788       0.74       48,688       0.30  
Less: Preferred dividends
    12,870       0.21             0.00  
 
                       
 
                               
Net income available to common stockholders and participating securities
    31,918       0.53       48,688       0.30  
 
                               
Gain on early retirement of debt
    (15,316 )     (0.25 )            
Estimated income tax expense (b)
    6,457       0.10              
 
                       
 
    23,059       0.38       48,688       0.30  
 
                               
Allocation to participating securities:
                               
Less: Earnings allocated to preferred stockholders
    2,250       0.04             0.00  
Less: Earnings allocated to unvested restricted stockholders
    320       0.00       97       0.00  
 
                       
 
                               
Adjusted net income available to common stockholders
  $ 20,489     $ 0.34     $ 48,591     $ 0.30  
 
                           
Adjustment for dilution
            0.00               0.00  
 
                           
 
                               
Adjusted net income available to common stockholders — diluted shares
          $ 0.34             $ 0.30  
 
                           
 
                               
Weighted average common shares outstanding:
                               
Basic
            60,509               159,686  
Diluted
            60,991               159,984  
     
(a)  
Per share amounts for each period presented are based on basic weighted average common shares outstanding for all amounts except adjusted net income available to common stockholders — diluted shares, which is based on diluted shares outstanding.
 
(b)  
Represents the tax expense on the adjustments to net income.